Roger Allen Sabbadini
Corporate Officer/Principal at San Diego State University
Profile
Dr. Roger A.
Sabbadini is a Director & Chief Scientific Officer at Vaxiion Therapeutics, Inc., Vice President at Lpath, Inc., and a Professor-Emeritus at San Diego State University.
He is on the Board of Directors at Vaxiion Therapeutics, Inc.
Dr. Sabbadini was previously employed as Chief Scientific Officer by Lpath Therapeutics, Inc.
He received his doctorate degree from the University of California, Davis.
Roger Allen Sabbadini active positions
Companies | Position | Start |
---|---|---|
San Diego State University | Corporate Officer/Principal | - |
Former positions of Roger Allen Sabbadini
Companies | Position | End |
---|---|---|
Lpath Therapeutics, Inc.
Lpath Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Boston Scientific Corp., Lpath Therapeutics, Inc. develops pharmaceutical products focused on bioactive signaling lipids as targets for treating and diagnosing important human diseases. The company is based in San Diego, CA. Lpath Therapeutics was acquired by Neighborhood Connections, Inc. on November 30, 2005 for $23.13 million. | Chief Tech/Sci/R&D Officer | - |
Vaxiion Therapeutics, Inc.
Vaxiion Therapeutics, Inc. BiotechnologyHealth Technology Vaxiion Therapeutics, Inc. operates as a biotechnology company. Its nanodelivery platforms are based on genetically engineered, non-living bacterial minicells that are capable of packaging, targeting and delivering a wide array of therapeutically relevant molecules (including protein toxins, small molecule drugs, RNAi, plasmids, peptides and imaging agents) directly to cancer cells. The company was founded by Roger Allen Sabbadini, Neil L. Berkley and William Gerhart in 2000 and is headquartered in San Diego, CA. | Founder | - |
Lpath, Inc.
Lpath, Inc. BiotechnologyHealth Technology Lpath, Inc. operates as a biotechnology company, which focuses on the discovery and development of lipidomic-based therapeutic antibodies, an emerging field of medical science that targets bioactive signaling lipids to treat a wide range of human diseases. It develops three drug candidates, each of them into clinical trials, and built evidence to support their approach of targeting bioactive lipids to treat a wide range of diseases. The company was founded by Roger Allen Sabbadini in September 1997 and is headquartered in San Diego, CA. | Founder | - |
Training of Roger Allen Sabbadini
University of California, Davis | Doctorate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
Lpath, Inc.
Lpath, Inc. BiotechnologyHealth Technology Lpath, Inc. operates as a biotechnology company, which focuses on the discovery and development of lipidomic-based therapeutic antibodies, an emerging field of medical science that targets bioactive signaling lipids to treat a wide range of human diseases. It develops three drug candidates, each of them into clinical trials, and built evidence to support their approach of targeting bioactive lipids to treat a wide range of diseases. The company was founded by Roger Allen Sabbadini in September 1997 and is headquartered in San Diego, CA. | Health Technology |
Lpath Therapeutics, Inc.
Lpath Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Boston Scientific Corp., Lpath Therapeutics, Inc. develops pharmaceutical products focused on bioactive signaling lipids as targets for treating and diagnosing important human diseases. The company is based in San Diego, CA. Lpath Therapeutics was acquired by Neighborhood Connections, Inc. on November 30, 2005 for $23.13 million. | Health Technology |
Vaxiion Therapeutics, Inc.
Vaxiion Therapeutics, Inc. BiotechnologyHealth Technology Vaxiion Therapeutics, Inc. operates as a biotechnology company. Its nanodelivery platforms are based on genetically engineered, non-living bacterial minicells that are capable of packaging, targeting and delivering a wide array of therapeutically relevant molecules (including protein toxins, small molecule drugs, RNAi, plasmids, peptides and imaging agents) directly to cancer cells. The company was founded by Roger Allen Sabbadini, Neil L. Berkley and William Gerhart in 2000 and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Roger Allen Sabbadini